Suppr超能文献

巴拿马夜猴体内恶性疟原虫对氯喹耐药性的逆转

Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys.

作者信息

Kyle D E, Milhous W K, Rossan R N

机构信息

Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington, DC.

出版信息

Am J Trop Med Hyg. 1993 Jan;48(1):126-33. doi: 10.4269/ajtmh.1993.48.126.

Abstract

An Aotus-Plasmodium falciparum model was used to determine if chloroquine resistance could be reversed in vivo. The putative resistance modulators tested all reverse chloroquine resistance in vitro and included verapamil, chlorpromazine, prochlorperazine, cyproheptadine, ketotifen, a tiapamil analog (Ro 11-2933), and a chlorpromazine analog (SKF 2133-A). Combinations of chloroquine plus chlorpromazine or prochlorperazine confirmed reversal of chloroquine resistance as exhibited by cures obtained in six Aotus monkeys infected with chloroquine-resistant P. falciparum (Vietnam Smith/RE strain) and rapid clearance of parasitemia, followed by recrudescence in six additional monkeys. The results indicate the following order of in vivo efficacy for reversing chloroquine resistance in Aotus: chlorpromazine > prochlorperazine >> desipramine >> Ro 11-2933 (tiapamil analog) > ketotifen. Cyproheptadine and verapamil were not effective in reversing chloroquine resistance and probable drug toxicity was observed with these drugs in combination with chloroquine.

摘要

利用夜猴-恶性疟原虫模型来确定氯喹抗性在体内是否可以逆转。所测试的假定抗性调节剂在体外均能逆转氯喹抗性,包括维拉帕米、氯丙嗪、丙氯拉嗪、赛庚啶、酮替芬、一种替帕米类似物(Ro 11-2933)以及一种氯丙嗪类似物(SKF 2133-A)。氯喹与氯丙嗪或丙氯拉嗪的联合用药证实了氯喹抗性的逆转,这表现为感染氯喹抗性恶性疟原虫(越南史密斯/RE株)的6只夜猴被治愈,疟原虫血症迅速清除,随后另外6只猴子复发。结果表明在夜猴体内逆转氯喹抗性的体内疗效顺序如下:氯丙嗪>丙氯拉嗪>>地昔帕明>>Ro 11-2933(替帕米类似物)>酮替芬。赛庚啶和维拉帕米在逆转氯喹抗性方面无效,并且观察到这些药物与氯喹联合使用时可能存在药物毒性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验